- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
UCB SA ADR (UCBJY)
Track the UCB ADR share price today and view real-time UCBJY share price data, including charts, technicals, and key financials. View the UCBJY premarket stock price ahead of the market session or assess the after hours quote. Explore UCBJY stock price movements, trading volume, and market activity across the OTC exchange.
What Is the UCB ADR Stock Price Today?
The UCB ADR stock price today is 148.01.
What Is the Stock Symbol for UCB ADR?
The stock symbol for UCB ADR is ""UCBJY.""
What Stock Exchange Does UCB ADR Trade On?
UCB ADR is listed and trades on the OTC Markets stock exchange.
Is UCB ADR a Good Stock to Buy?
Determining whether UCB ADR or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the UCBJY quote. (ISIN: US9034801012)
What Is the UCB ADR Stock Price Today?
The UCB ADR stock price today is 148.01.
What Is the Stock Symbol for UCB ADR?
The stock symbol for UCB ADR is ""UCBJY.""
What Stock Exchange Does UCB ADR Trade On?
UCB ADR is listed and trades on the OTC Markets stock exchange.
Is UCB ADR a Good Stock to Buy?
Determining whether UCB ADR or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the UCBJY quote. (ISIN: US9034801012)
148.01
0.00(0.00%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
144.52
148.42
52 wk Range
71.16
168.76
UCBJY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
144.52148.42
52 wk Range
71.16168.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
UCBJY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
163.15
Upside
+10.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Ucb receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Ucb receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
UCB SA ADR Company Profile
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson’s disease and restless legs syndrome. It also provides Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. In addition, the company offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx to treat plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; Fintepla for the treatment of Dravet and Lennox-Gastaut syndrome; and RYSTIGGO and ZILBRYSQ to treat people living with generalized myasthenia gravis. Further, it develops KYGEVVI (doxecitine/doxribtimine) for thymidine kinase 2 deficiency disorder; fenfluramine to treat CDKL5 deficiency disorder, and RETT-Syndrome; dapirolizumab pegol for systemic lupus erythematosus; STACCATO alprazolam for treating stereotypical prolonged seizures; bepranemab to treat Alzheimer’s disease; and UCB9741 for atopic dermatitis, non cystic fibrosis bronchiectasis, and chronic obstructive pulmonary disease. Additionally, it engages in the contract manufacturing activities. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Compare UCBJY to Peers and Sector
Metrics to compare | UCBJY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipUCBJYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.8x | 22.3x | −0.5x | |
PEG Ratio | 0.66 | 0.32 | 0.00 | |
Price/Book | 4.6x | 3.8x | 2.6x | |
Price / LTM Sales | 6.4x | 2.8x | 3.2x | |
Upside (Analyst Target) | 10.3% | 23.3% | 50.1% | |
Fair Value Upside | Unlock | 16.9% | 8.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 163.15
(+10.23% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 2.37B
People Also Watch
FAQ
What Is the UCB ADR (UCBJY) Stock Price Today?
The UCB ADR stock price today is 148.01 USD.
What Stock Exchange Does UCB ADR Trade On?
UCB ADR is listed and trades on the OTC Markets.
What Is the Stock Symbol for UCB ADR?
The stock symbol for UCB ADR is "UCBJY."
Does UCB ADR Pay Dividends? What’s The Current Dividend Yield?
The UCB ADR dividend yield is 0.33%.
What Is the UCB ADR Market Cap?
As of today, UCB ADR market cap is 58.31B USD.
What Is UCB ADR's Earnings Per Share (TTM)?
The UCB ADR EPS (TTM) is 8.19.
When Is the Next UCB ADR Earnings Date?
UCB ADR will release its next earnings report on 22/04/2026.
From a Technical Analysis Perspective, Is UCBJY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has UCB ADR Stock Split?
UCB ADR has split 0 times.
How Many Employees Does UCB ADR Have?
UCB ADR has 9765 employees.
What is the current trading status of UCB ADR (UCBJY)?
As of 04/03/2026, UCB ADR (UCBJY) is trading at a price of 148.01 USD, with a previous close of 148.01 USD. The stock has fluctuated within a day range of 144.52 USD to 148.42 USD, while its 52-week range spans from 71.16 USD to 168.76 USD.
What Is UCB ADR (UCBJY) Price Target According to Analysts?
The average 12-month price target for UCB ADR is 163.15 USD, with a high estimate of 167.08323673 USD and a low estimate of 159.22095989 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +10.23% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.